Facilitating the research of numerous nationally and internationally recognized scientists, in over sixty labs across British Columbia, to improve cancer care.

BC Cancer Research strives to improve the lives of patients through the integration of basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the development of innovative new technology, programs, and interventions. Organized through departments and programs with various themes, BC Cancer supports groundbreaking cancer research and personalized care approaches through world-class facilities and platforms including genomics, bioinformatics, imaging, drug development and tissue banking.

Our Research

The success of BC Cancer is driven by the people and their passion to reduce the impact of cancer on people and society. Our 2023 Research Report showcases how BC Cancer continues to be internationally recognized for our excellence in cancer research and its integrated model of cancer planning and care. 

Read the 2023 BC Cancer Research Report

News & Events

Canadian and US cancer researchers form special super team to improve treatments and outcomes for patients with osteosarcoma, the rare bone cancer that Terry Fox had

In a national first, a team of top Canadian cancer researchers, including BC Cancer distinguished scientist Dr. Poul Sorensen, is joining forces with world-class US scientists at leading cancer institutes south of the border to tackle together the challenges of osteosarcoma (bone cancer), or what is sometimes called the Terry Fox cancer.

Dr. Poul Sorensen honoured with Dr. Chew Wei Memorial Prize in Cancer Research

The 2025 Dr. Chew Wei Memorial Prize in Cancer Research was awarded to Dr. Poul Sorensen for his revolutionary contributions to pediatric cancer diagnostics and care. The award is a UBC Faculty of Medicine National Research Prize, which celebrates individuals who exemplify excellence in scientific research and ongoing impact in their respective fields.

Research Recovery Resources

BC Cancer Research is taking a gradual and careful approach to re-opening research activities to protect our staff, patients and communities.

Access our COVID-19 recovery resources.

Our Strategic Plan

Our Strategic Plan outlines our direction to strengthen our research capabilities and collaboration with departments and partners to improve our ability to generate knowledge, enhance the impact of our research, and support innovation in clinical care.  

Read the BC Cancer Research Strategic Plan.

Facilitating research excellence through management of day-to-day operations.

Office of Research Administration

Conducting research to improve the prevention, detection and treatment of cancer.

Population Health Sciences

Developing and deploying genomics technologies and services in support of cancer and life sciences research.

Genome Sciences Centre

Making novel discoveries in the biology underlying normal development and cancer progression.

Terry Fox Laboratory

Characterising the molecular changes that underpin the progression and pathogenesis of cancer.

Molecular Oncology

Researching the optical, radiobiological and genetic properties of cancer.

Integrative Oncology

Improving patient outcomes by gaining a deeper understanding of lymphoma biology and progression, for use in clinical applications.

Lymphoid Cancer Research

Defining better intervention strategies for individuals diagnosed with aggressive cancers.

Experimental Therapeutics

Clinical Research

Harnessing the immune system to detect and treat cancer.

Deeley Research Centre

The Nursing and Allied Health Research and Knowledge Translation department promotes innovation and excellence in interprofessional research and knowledge mobilization to drive evidence-informed improvements in care, better patient outcomes and increased system performance.

Nursing and Allied Health Research and Knowledge Translation

Publications

Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease.

Science translational medicine, 2021
Nakamura, Akihiro, Zeng, Fanxing, Nakamura, Sayaka, Reid, Kyle T, Gracey, Eric, Lim, Melissa, Leng, Lin, Jo, Sungsin, Park, Ye-Soo, Kusuda, Masaki, Machhar, Rohan, Boroojeni, Shaghayegh F, Wu, Brian, Rossomacha, Evgeny, Kim, Tae-Hwan, Ciccia, Francesco, Rockel, Jason S, Kapoor, Mohit, Inman, Robert D, Jurisica, Igor, Crome, Sarah Q, Bucala, Richard, Haroon, Nigil
Learn More

A distinct innate lymphoid cell population regulates tumor-associated T cells.

Nature medicine, 2017
Crome, Sarah Q, Nguyen, Linh T, Lopez-Verges, Sandra, Yang, S Y Cindy, Martin, Bernard, Yam, Jennifer Y, Johnson, Dylan J, Nie, Jessica, Pniak, Michael, Yen, Pei Hua, Milea, Anca, Sowamber, Ramlogan, Katz, Sarah Rachel, Bernardini, Marcus Q, Clarke, Blaise A, Shaw, Patricia A, Lang, Philipp A, Berman, Hal K, Pugh, Trevor J, Lanier, Lewis L, Ohashi, Pamela S
Learn More

Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity.

Nature communications, 2022
McEvoy, Caitriona M, Murphy, Julia M, Zhang, Lin, Clotet-Freixas, Sergi, Mathews, Jessica A, An, James, Karimzadeh, Mehran, Pouyabahar, Delaram, Su, Shenghui, Zaslaver, Olga, Röst, Hannes, Arambewela, Rangi, Liu, Lewis Y, Zhang, Sally, Lawson, Keith A, Finelli, Antonio, Wang, Bo, MacParland, Sonya A, Bader, Gary D, Konvalinka, Ana, Crome, Sarah Q
Learn More
Back to top